Regulation of G2/M events by Cdc25A through phosphorylation‐dependent modulation of its stability
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
DNA replication in higher eukaryotes requires activation of a Cdk2 kinase by Cdc25A, a labile phosphatase subject to further destabilization upon genotoxic stress. We describe a distinct, markedly stable form of Cdc25A, which plays a previously unrecognized role in mitosis. Mitotic stabilization of Cdc25A reflects its phosphorylation on Ser17 and Ser115 by cyclin B-Cdk1, modifications required to uncouple Cdc25A from its ubiquitin-proteasome-mediated turnover. Cdc25A binds and activates cyclin B-Cdk1, accelerates cell division when overexpressed, and its downregulation by RNA interference (RNAi) delays mitotic entry. DNA damage-induced G(2) arrest, in contrast, is accompanied by proteasome-dependent destruction of Cdc25A, and ectopic Cdc25A abrogates the G(2) checkpoint. Thus, phosphorylation-mediated switches among three differentially stable forms ensure distinct thresholds, and thereby distinct roles for Cdc25A in multiple cell cycle transitions and checkpoints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The occurrence of DNA damage response in G2-phase, leads to checkpoint mediator (claspin) dependent activation of Chk1/2, followed by SCFβTrcP mediated degradation of CDK-activating phosphatase Cdc25A [341, 342], that results in arrest of multiple cell-cycle transition including the G2 checkpoint [343, 344].”
From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [344]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Analytical Properties of the Nanoelectrospray Ion Source
Wilm, M., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac9509519 · Cited by 1,868
Self-citationMitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Shevchenko, A., Jensen, O. N., Podtelejnikov, A. V., Sagliocco, F., Wilm, M., Vorm, O., Mortensen, P., Shevchenko, A., Boucherie, H., & Mann, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14440 · Cited by 1,427
Self-citationMeijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Cited by
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Self-citationMolecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair
Rastogi, R. P., Richa, Kumar, A., Tyagi, M. B., & Sinha, R. P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/592980 · Cited by 1,329
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
DNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784
Self-citationChecking on DNA damage in S phase
Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758
Self-citationCDC25 phosphatases in cancer cells: key players? Good targets?
Boutros, R., Lobjois, V., & Ducommun, B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2169 · Cited by 714
The decision to enter mitosis: feedback and redundancy in the mitotic entry network
Lindqvist, A., Rodríguez-Bravo, V., & Medema, R. H. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200812045 · Cited by 565
Syljuåsen, R. G., Sørensen, C. S., Hansen, L. T., Fugger, K., Lundin, C., Johansson, F., Helleday, T., Sehested, M., Lukas, J., & Bartek, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3553-3562.2005 · Cited by 550
Self-citationConsequences of the selective blockage of chaperone-mediated autophagy
Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., & Cuervo, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507436103 · Cited by 529
Regulating mammalian checkpoints through Cdc25 inactivation
Donzelli, M., & Draetta, G. F. (2003) · EMBO reports · doi:10.1038/sj.embor.embor887 · Cited by 438
Manke, I. A., Nguyen, A., Lim, D., Stewart, M. Q., Elia, A. E. H., & Yaffe, M. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.021 · Cited by 416
The when and wheres of CDC25 phosphatases
Boutros, R., Dozier, C., & Ducommun, B. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.02.003 · Cited by 414
Targeting the checkpoint kinases: chemosensitization versus chemoprotection
Zhou, B.-B. S., & Bartek, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1296 · Cited by 391
Polo-like Kinase-1 Controls Recovery from a G2 DNA Damage-Induced Arrest in Mammalian Cells
van Vugt, M. A. T. M., Brás, A., & Medema, R. H. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.015 · Cited by 385
Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time
Lukas, J., Lukas, C., & Bartek, J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.006 · Cited by 381
Self-citationSCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S. J., & Harper, J. W. (2003) · Genes & Development · doi:10.1101/gad.1157503 · Cited by 340
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
Turner, N. C., Lord, C. J., Iorns, E., Brough, R., Swift, S., Elliott, R., Rayter, S., Tutt, A. N., & Ashworth, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.61 · Cited by 322
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells
Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Lazo, J. S., Wang, Z., Zhang, L., & Yu, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1996 · Cited by 308
A mitosis-specific and R loop–driven ATR pathway promotes faithful chromosome segregation
Kabeche, L., Nguyen, H. D., Buisson, R., & Zou, L. (2018) · Science · doi:10.1126/science.aan6490 · Cited by 303
Peschiaroli, A., Dorrello, N. V., Guardavaccaro, D., Venere, M., Halazonetis, T., Sherman, N. E., & Pagano, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.013 · Cited by 289
ATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.169730 · Cited by 271
14-3-3 proteins as signaling integration points for cell cycle control and apoptosis
Gardino, A. K., & Yaffe, M. B. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.008 · Cited by 263
Mailand, N., Bekker-Jensen, S., Bartek, J., & Lukas, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.016 · Cited by 258
Self-citationStojic, L., Mojas, N., Cejka, P., di Pietro, M., Ferrari, S., Marra, G., & Jiricny, J. (2004) · Genes & Development · doi:10.1101/gad.294404 · Cited by 246
“…kinase-dead protein (Paul Nghiem, Harvard University, Cambridge, MA) was maintained in DMEM supplemented with 10% FCS, 200 µg/mL G418, and 200 µg/mL Hygromycin B. Induction of ATR-kd was accomplished by supplementing the growth medium with Dox (1 µg/mL) for 48 h, as described (Nghiem et al. 2002).”
BackgroundMethodInfluentialChk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding
Chen, M.-S., Ryan, C. E., & Piwnica-Worms, H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7488-7497.2003 · Cited by 238
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis
Shen, T., & Huang, S. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800617678 · Cited by 225
Calcium signaling and cell cycle: Progression or death
Humeau, J., Bravo-San Pedro, J. M., Vitale, I., Nuñez, L., Villalobos, C., Kroemer, G., & Senovilla, L. (2018) · Cell Calcium · doi:10.1016/j.ceca.2017.07.006 · Cited by 217
Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis
Busino, L., Chiesa, M., Draetta, G. F., & Donzelli, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207394 · Cited by 211
Targeting CDK1 in cancer: mechanisms and implications
Wang, Q., Bode, A. M., & Zhang, T. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00407-7 · Cited by 203
Lindqvist, A., Källström, H., Lundgren, A., Barsoum, E., & Rosenthal, C. K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503066 · Cited by 200
Zhang, X., Neganova, I., Przyborski, S., Yang, C., Cooke, M., Atkinson, S. P., Anyfantis, G., Fenyk, S., Keith, W. N., Hoare, S. F., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200801009 · Cited by 197
Sur, S., & Agrawal, D. K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2693-2 · Cited by 190
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest
Ujiki, M. B., Ding, X.-Z., Salabat, M. R., Bentrem, D. J., Golkar, L., Milam, B., Talamonti, M. S., Bell, R. H., Iwamura, T., & Adrian, T. E. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-76 · Cited by 184
“Cdc25A also contributes to the cellular phosphatase pool required to dephosphorylate cdc2 fully [27].”
Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M Transition
Timofeev, O. N., Cizmecioglu, O., Settele, F., Kempf, T., & Hoffmann, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096552 · Cited by 178
Cell cycle in mouse development
Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208608 · Cited by 172
Elucidating Human Phosphatase-Substrate Networks
Li, X., Wilmanns, M., Thornton, J., & Köhn, M. (2013) · Science Signaling · doi:10.1126/scisignal.2003203 · Cited by 171
Regulation of mitotic entry by microcephalin and its overlap with ATR signalling
Alderton, G. K., Galbiati, L., Griffith, E., Surinya, K. H., Neitzel, H., Jackson, A. P., Jeggo, P. A., & O'Driscoll, M. (2006) · Nature Cell Biology · doi:10.1038/ncb1431 · Cited by 167
Kang, T., Wei, Y., Honaker, Y., Yamaguchi, H., Appella, E., Hung, M.-C., & Piwnica-Worms, H. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.002 · Cited by 164
Ferguson, A. M., White, L. S., Donovan, P. J., & Piwnica-Worms, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2853-2860.2005 · Cited by 164
Ashwell, S., & Zabludoff, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5138 · Cited by 163
Plk1 regulates mitotic Aurora A function through βTrCP-dependent degradation of hBora
Chan, E. H. Y., Santamaria, A., Silljé, H. H. W., & Nigg, E. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0165-5 · Cited by 160
Multiple PIP2 binding sites in Kir2.1 inwardly rectifying potassium channels
Soom, M., Schönherr, R., Kubo, Y., Kirsch, C., Klinger, R., & Heinemann, S. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02136-6 · Cited by 153
The role of the ubiquitin/proteasome system in cellular responses to radiation
McBride, W. H., Iwamoto, K. S., Syljuåsen, R. G., Pervan, M., & Pajonk, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206676 · Cited by 153
Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
Durkin, S. G., Arlt, M. F., Howlett, N. G., & Glover, T. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209466 · Cited by 151
Hirose, Y., Katayama, M., Mirzoeva, O. K., Berger, M. S., & Pieper, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2633 · Cited by 151
The Mammalian Cell Cycle: An Overview
Harper, J. V., & Brooks, G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-857-9:113 · Cited by 150
NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint
Melixetian, M. B., Klein, D. K., Sørensen, C. S., & Helin, K. (2009) · Nature Cell Biology · doi:10.1038/ncb1969 · Cited by 149
Oncogenic MicroRNAs: Key Players in Malignant Transformation
Frixa, T., Donzelli, S., & Blandino, G. (2015) · Cancers · doi:10.3390/cancers7040904 · Cited by 147
How protein kinases co-ordinate mitosis in animal cells
Ma, H. T., & Poon, R. Y. C. (2011) · Biochemical Journal · doi:10.1042/bj20100284 · Cited by 145
Phosphorylation of histone H2AX at M phase in human cells without DNA damage response
Ichijima, Y., Sakasai, R., Okita, N., Asahina, K., Mizutani, S., & Teraoka, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.164 · Cited by 142
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A
Pereg, Y., Liu, B. Y., O’Rourke, K. M., Sagolla, M. S., Dey, A., Kömüves, L. G., French, D. M., & Dixit, V. M. (2010) · Nature Cell Biology · doi:10.1038/ncb2041 · Cited by 142
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Uto, K., Inoue, D., Shimuta, K., Nakajo, N., & Sagata, N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600328 · Cited by 134
“In response to genotoxic stress, Chk1 and Chk2 phosphorylate Cdc25A on N-terminal sites and target it rapidly for ubiquitin-dependent degradation (Mailand et al, 2000, 2002; Molinari et al, 2000; Falck et al, 2001; Shimuta et al, 2002; Busino et al, 2003), which is thought to be central to the S…”
BackgroundInfluentialThe DNA damage response during mitosis
Heijink, A. M., Krajewska, M., & van Vugt, M. A. T. M. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.07.003 · Cited by 129
Kanemori, Y., Uto, K., & Sagata, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501873102 · Cited by 128
DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease
Ducruet, A. P., Vogt, A., Wipf, P., & Lazo, J. S. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100040 · Cited by 120
Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis
Schmidt, A., Durgan, J., Magalhães, A., & Hall, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601637 · Cited by 117
Campos, A., & Clemente‐Blanco, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020446 · Cited by 117
Kittipatarin, C., & Khaled, A. R. (2007) · Cytokine · doi:10.1016/j.cyto.2007.07.183 · Cited by 115
DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment
Liang, Y., Lin, S., Brunicardi, F. C., Goss, J. A., & Li, K. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9840-1 · Cited by 114
Role of Checkpoint Kinase 1 in Preventing Premature Mitosis in Response to Gemcitabine
Morgan, M. A., Parsels, L. A., Parsels, J. D., Mesiwala, A. K., Maybaum, J., & Lawrence, T. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2246 · Cited by 112
Fission yeast Clp1p phosphatase affects G2/M transition and mitotic exit through Cdc25p inactivation
Wolfe, B. A., & Gould, K. L. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600103 · Cited by 112
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 110
Herman-Antosiewicz, A., & Singh, S. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501443200 · Cited by 106
Crncec, A., & Hochegger, H. (2019) · FEBS Letters · doi:10.1002/1873-3468.13635 · Cited by 103
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
García-Reyes, B., Kretz, A.-L., Ruff, J.-P., von Karstedt, S., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., & Lemke, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103219 · Cited by 102
Cesaretti, J. A., Stock, R. G., Lehrer, S. P., Atencio, D. A., Bernstein, J. L., Stone, N. N., Wallenstein, S. R., Green, S., Loeb, K., Kollmeier, M. A., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.031 · Cited by 102
Phosphatases in Mitosis: Roles and Regulation
Moura, M., & Conde, C. (2019) · Biomolecules · doi:10.3390/biom9020055 · Cited by 101
Functional cdc25C Dual-Specificity Phosphatase Is Required for S-Phase Entry in Human Cells
Turowski, P., Franckhauser, C., Morris, M. C., Vaglio, P., Fernandez, A., & Lamb, N. J. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-08-0515 · Cited by 100
Syljuåsen, R. G., Sørensen, C. S., Nylandsted, J., Lukas, C., Lukas, J., & Bartek, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2434 · Cited by 99
“This finding is consistent with previous reports in which cells lacking Cdc25C showed a normal G2 checkpoint response (11) and with the involvement of Cdc25A in the G2 checkpoint (4, 10).”
ResultSelf-citationAlkhalil, A., Hammamieh, R., Hardick, J. P., Ichou, M. A., Jett, M., & Ibrahim, S. M. (2010) · Virology Journal · doi:10.1186/1743-422x-7-173 · Cited by 99
Carrassa, L., Broggini, M., Erba, E., & Damia, G. L. M. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1080 · Cited by 98
Chow, J. P. H., Siu, W. Y., Ho, H. T. B., Ma, H. T., Ho, C. C., & Poon, R. Y. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306683200 · Cited by 98
Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation
Bahassi, E. M., Hennigan, R. F., Myer, D. L., & Stambrook, P. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207425 · Cited by 98
How adeno-associated virus Rep78 protein arrests cells completely in S phase
Berthet, C., Raj, K., Saudan, P., & Beard, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504583102 · Cited by 97
Sensing and Integration of Erk and PI3K Signals by Myc
Lee, T., Yao, G., Nevins, J. R., & You, L. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000013 · Cited by 95
Brenner, A. K., Reikvam, H., Lavecchia, A., & Bruserud, Ø. (2014) · Molecules · doi:10.3390/molecules191118414 · Cited by 95
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Kiyokawa, H., & Ray, D. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008786847693 · Cited by 93
Rudolph, J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2087 · Cited by 91
Krämer, A., Lukas, J., & Bártek, J. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1252 · Cited by 90
Self-citationWang, L., Baiocchi, R. A., Pal, S., Mosialos, G., Caligiuri, M. A., & Sif, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.7953-7965.2005 · Cited by 89
Methylator-induced, Mismatch Repair-dependent G2Arrest Is Activated through Chk1 and Chk2
Adamson, A. W., Beardsley, D. I., Kim, W.-J., Gao, Y., Baskaran, R., & Brown, K. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0089 · Cited by 88
The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage
Lee, J.-H., Kang, Y. J., Khare, V., Jin, Z.-Y., Kang, M.-Y., Yoon, Y. M., Hyun, J.-W., Chung, M.-H., Cho, S.-I., Jun, J. Y., et al. (2009) · Oncogene · doi:10.1038/onc.2009.438 · Cited by 86
ATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.188631 · Cited by 84
3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation
Jin, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0985-0 · Cited by 84
Brisson, M., Nguyen, T. P. T., Vogt, A., Yalowich, J. C., Giorgianni, A., Tobi, D., Bahar, İ., Stephenson, C. R. J., Wipf, P., & Lazo, J. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001784 · Cited by 83
CDC25A phosphatase controls meiosis I progression in mouse oocytes
Solc, P., Šašková, A., Baran, V., Kubelka, M., Schultz, R. M., & Motlík, J. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.028 · Cited by 83
α-Endosulfine is a conserved protein required for oocyte meiotic maturation inDrosophila
Stetina, J. R. V., Tranguch, S. L., Dey, S. K., Lee, L. A., Cha, B., & Drummond‐Barbosa, D. (2008) · Development · doi:10.1242/dev.025114 · Cited by 82
Hassepass, I., Voit, R., & Hoffmann, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302704200 · Cited by 78
Lindqvist, A., Källström, H., & Karlsson, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01395 · Cited by 76
Keeping checkpoint kinases in line: new selective inhibitors in clinical trials
Ashwell, S., Janetka, J. W., & abludoff, S. Z. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.9.1331 · Cited by 76
The ubiquitin-proteasome pathway in cell cycle control
Reed, S. I. (2006) · Springer eBooks · doi:10.1007/b136681 · Cited by 74
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A
Rother, K., Kirschner, R., Sänger, K., Böhlig, L., Mössner, J., & Engeland, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209989 · Cited by 74
Cytokine-driven cell cycling is mediated through Cdc25A
Khaled, A. R., Bulavin, D. V., Kittipatarin, C., Li, W., Alvarez, M., Kim, K., Young, H. A., Fornace, A. J., & Durum, S. K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409099 · Cited by 74
Physiological Aspects of UV-Excitation of DNA
RICHA, R., Sinha, R. P., & Häder, D. (2014) · Topics in current chemistry · doi:10.1007/128_2014_531 · Cited by 73
A Novel Synthetic Inhibitor of CDC25 Phosphatases
Brézak, M.-C., Quaranta, M., Mondésert, O., Contour-Galcéra, M.-O., Lavergne, O., Alby, F., Cazalès, M., Baldin, V., Thurieau, C., Harnett, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3984 · Cited by 73
Li‐Weber, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29013 · Cited by 72
Dual role of CDKs in DNA repair: To be, or not to be
Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 71
Li, Y., Zhao, S., Zhen, Y., Li, Q., Teng, L., Asai, A., & Kawamoto, K. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-011-0037-1 · Cited by 70
Metadata
- Authors
- Mailand, N., Podtelejnikov, A. V., Groth, A., Mann, M., Bartek, J., & Lukas, J.
- Affiliations
- Danish Cancer Society (DK)
- University of Southern Denmark (DK)
- Corresponding author
- Bartek, Jiri
- Venue
- The EMBO Journal
- Published
- 2002-11-01
- Volume
- 21
- Issue
- 21
- Pages
- 5911-5920
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC131064
- OpenAlex
- W1976558883
- Cited by
- 315
- References
- 62
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 12 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 10 · 2016: 11 · 2015: 10 · 2014: 7 · 2013: 14 · 2012: 15
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- CDC25A, G2/M transition, mitosis, protein stability, phosphorylation, CDK1/cyclin B, ubiquitin-proteasome degradation, DNA damage checkpoint, G2 checkpoint, CDK2 activation, cell cycle regulation, protein phosphatase
- MeSH terms
- Amino Acid Sequence, Animals, DNA Damage, Enzyme Stability, Humans, Mitosis, Molecular Sequence Data, Phosphorylation, Serine, G2 Phase, CDC2 Protein Kinase, Cyclin B, cdc25 Phosphatases, Ubiquitin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.